Home > Insider Trading > Filing (0001209191-20-056658)

Filing Details

Accession Number:: 0001209191-20-056658
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-11-03 16:49:24
Reporting Period:: 2020-11-02

Accepted Time:: 2020-11-03 16:49:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1124140	Exact Sciences Corp	EXAS	Services-Commercial Physical & Biological Research (8731)	204782291

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1306119	T Kevin Conroy	C/O Exact Sciences Corp. 5505 Endeavor Lane Madison WI 53719	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-11-02	4,393	$118.32	916,521	No	4	S	Direct
Common Stock	Disposition	2020-11-02	1,108	$119.18	915,413	No	4	S	Direct
Common Stock	Disposition	2020-11-02	6,512	$120.45	908,901	No	4	S	Direct
Common Stock	Disposition	2020-11-02	10,229	$121.52	898,672	No	4	S	Direct
Common Stock	Disposition	2020-11-02	9,577	$122.33	889,095	No	4	S	Direct
Common Stock	Disposition	2020-11-02	600	$123.45	888,495	No	4	S	Direct
Common Stock	Disposition	2020-11-02	400	$124.71	888,095	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	26,305	Indirect	Held in 401(k) Plan
Common Stock	21,730	Indirect	Held in Grantor Retained Annuity Trust
Common Stock	21,730	Indirect	Held in Grantor Retained Annuity Trust
Common Stock	21,729	Indirect	Held in Grantor Retained Annuity Trust

Footnotes

The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan, which trading plan was disclosed via Form 8-K filed by Exact Sciences Corporation with the U.S. Securities and Exchange Commission on November 27, 2019.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.81 to $118.69, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.81 to $119.67, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.87 to $120.86, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.92 to $121.91, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.92 to $122.91, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.18 to $123.78, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.36 to $125.02, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
In addition to the shares of Common Stock reported on this Form 4, which total 979,589 shares, Mr. Conroy also holds, in the aggregate, an additional 1,279,310 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.